ArticleThe oncologist2019

Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.

Yao Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.